-
ACLA White Paper: Considerations for Appropriate Use of SARS-CoV-2 Testing
-
Ambry Genetics lab adapts to bring crucial COVID-19 tests to patients
This Laboratory Professionals Week, we honor the innovators, collaborators and colleagues who have gone above and beyond behind the scenes to meet patient need. Today, ... Read More -
ACLA Comments on MCIT/Reasonable and Necessary Definition Proposed Rule
-
Rapid Change is the Name of the Game
This Laboratory Professionals Week, we honor the innovators, collaborators and colleagues who have gone above and beyond behind the scenes to meet patient need. Today, ... Read More -
ACLA Comments on United States Core Data for Interoperability (USCDI) Draft V2
-
ACLA Comments on Medicare Coverage of Innovative Technology (MCIT)
-
ACLA Statement on Recent Steps to Expand Testing
Washington, D.C. – Following the announcement of new steps and updated CDC guidelines to ramp up testing and help schools reopen, ACLA President Julie Khani ... Read More -
ACLA Elects 2021-2022 Board of Directors
Washington, D.C. – The American Clinical Laboratory Association (ACLA) today announced the election of its new Board of Directors for 2021-2022. William Morice II, M.D., Ph.D., ... Read More -
ACLA Statement on President Biden’s Actions to Close Coverage Gaps for COVID-19 Testing
Washington, D.C. Following the Biden Administration’s new guidance on coverage requirements for COVID-19 testing, ACLA President Julie Khani released the following statement: “President Biden’s decisive ... Read More -
ACLA Letter To Senate Finance Committee On Xavier Becerra’s Nomination
